| Revision as of 13:36, 25 September 2009 editEdgar181 (talk | contribs)Extended confirmed users196,325 edits drugbox data, etc.← Previous edit | Revision as of 05:24, 17 December 2009 edit undoSmackBot (talk | contribs)3,734,324 editsm remove Erik9bot category,outdated, tag and general fixesNext edit → | ||
| Line 1: | Line 1: | ||
| {{Unreferenced stub|auto=yes|date=December 2009}} | |||
| {{drugbox | |||
| {{Drugbox | |||
| | IUPAC_name = | | IUPAC_name = | ||
| | image = Tyloxapol.png | | image = Tyloxapol.png | ||
| Line 28: | Line 29: | ||
| '''Tyloxapol''' is a nonionic liquid ] of the alkyl aryl polyether alcohol type. It is used as a ] to aid ] and removal of mucopurulent (containing ] and ]) bronchopulmonary secretions, administered by inhalation through a ] or with a stream of oxygen. | '''Tyloxapol''' is a nonionic liquid ] of the alkyl aryl polyether alcohol type. It is used as a ] to aid ] and removal of mucopurulent (containing ] and ]) bronchopulmonary secretions, administered by inhalation through a ] or with a stream of oxygen. | ||
| With ], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of ]-rich ]s. | With ], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of ]-rich ]s. | ||
| ⚫ | {{ |
||
| {{Cough and cold preparations}} | {{Cough and cold preparations}} | ||
| ] | ] | ||
| ] | |||
| ⚫ | {{Pharma-stub}} | ||
| ] | ] | ||
Revision as of 05:24, 17 December 2009
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Tyloxapol" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660  |
| Chemical and physical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Molar mass | variable |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |